fda warning bpc 157 peptide products New Details 157 The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York of the Federal Food, Drug, and Cosmetic Act (FDCA).* Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law BPC 157 What Athletes Need to Know About Legality, Safety and Efficacy Training & Conditioning